Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Undecaprenyl phosphate, also known as bactoprenol phosphate, is a critical 55-carbon isoprenoid lipid carrier essential for the biosynthesis of the bacterial cell wall (PubChem CID 6433164). It functions as a membrane-bound shuttle that transports hydrophilic precursors, such as the N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) building blocks of peptidoglycan, across the cytoplasmic membrane (Manat et al., 2014, Microbial Drug Resistance). Once these precursors are delivered to the external side of the membrane for polymerization, the resulting undecaprenyl pyrophosphate must be dephosphorylated back to its monophosphate form to be reused in subsequent transport cycles (PubMed ID: 25130115). This recycling process is a major vulnerability in bacterial metabolism and is the primary target of the antibiotic bacitracin, which binds to the pyrophosphate intermediate and prevents its conversion back to the active monophosphate form (StatPearls, Bacitracin). Because this lipid carrier is indispensable for bacterial survival and lacks a direct human counterpart, it represents a highly effective target for antimicrobial therapy, particularly against Gram-positive pathogens (Nature Reviews Microbiology, 2005). Beyond peptidoglycan, it is also involved in the synthesis of other cell surface polysaccharides like teichoic acids and O-antigens (UniProt). Therapeutic challenges include the high nephrotoxicity of systemic agents targeting this pathway, which often limits their clinical use to topical applications (NIH LiverTox). Research continues into novel compounds that can sequester the lipid carrier directly to overcome resistance mechanisms (Nature Communications, 2017).
Inhibition of undecaprenyl pyrophosphate dephosphorylation, which prevents the regeneration of the active undecaprenyl phosphate carrier required for cell wall precursor transport (StatPearls, Bacitracin).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Undecaprenyl phosphate (Und-P) (Und-P).